Study of Efficacy of Oncology Dashboard in Improving Operational Efficiency and Patient Outcomes
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 92
- 试验地点
- 1
- 主要终点
- Time to complete medical oncology review (oncology workflow)
研究概览
简要总结
This clinical trial investigates whether measuring and presenting information about a patient's cancer treatment to them, their doctor, and their radiologist using a tool called an "oncology dashboard" may help patients understand the disease better and help the patient's medical team manage their care more efficiently. The oncology dashboard tool may help patients understand the disease better and may help improve the efficiency of their medical care.
详细描述
PRIMARY OBJECTIVE:
I. To compare the changes in oncology workflow times from baseline to follow up visits between intervention (follow-up visit with oncology dashboard tool) and control (follow-up visit without oncology dashboard tool) groups.
SECONDARY OBJECTIVES:
I. To compare the changes in radiology workflow times from baseline to follow up visits between intervention (follow-up visit with oncology dashboard tool) and control (follow-up visit without oncology dashboard tool) groups.
II. Assess and compare the proportion of patients who correctly indicate the changes in tumor size while on therapy at the baseline and at the follow-up visit (with the oncology dashboard tool).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with sarcoma on active chemotherapy/targeted therapy
- •Patients must have stable to mildly progressive disease or better on baseline assessment
- •Baseline measurement and follow-up measurement have to be performed on the same treatment for consistency. If patients with progressive disease are included into the study at baseline, follow-up measurement will be on a different treatment. Invariable, initiation of a new treatment, in the setting of progressive disease, lengthens oncology workflow which would affect the post measurement
- •Patients must have been on the same treatment for at least 6 weeks
- •Patients must have at least 3 prior imaging studies of the same body part/tracked lesion/area of interest separated by 6 weeks or more between studies
- •Patients should be continuing same therapy for the next 6-8 weeks
- •Patients must have plan for follow-up with imaging studies at MD Anderson Cancer Center (MDACC) while on therapy
- •Patients who are receiving therapy outside of MDACC but having their follow-up imaging at MDACC are eligible
- •>= 18 years of age
排除标准
- •Expected survival of less than 8 weeks
- •Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 4
- •Non- English-speaking patients and patients with cognitive impairment who cannot complete the questionnaire
研究组 & 干预措施
Group I (oncology dashboard)
Radiologist records information from patient's recent scan into oncology dashboard. Patients view images of how disease may have changed over time on oncology dashboard.
干预措施: Informational Intervention (Other)
Group I (oncology dashboard)
Radiologist records information from patient's recent scan into oncology dashboard. Patients view images of how disease may have changed over time on oncology dashboard.
干预措施: Questionnaire Administration (Other)
Group II (standard of care)
Patients receive standard of care.
干预措施: Best Practice (Other)
Group II (standard of care)
Patients receive standard of care.
干预措施: Questionnaire Administration (Other)
结局指标
主要结局
Time to complete medical oncology review (oncology workflow)
时间窗: through study completion, an average of 1 year
次要结局
未报告次要终点